Read the latest from Baszucki Group and its partners.
September 19, 2023 — University of California San Diego has begun enrolling participants in a clinical trial evaluating ketogenic therapy for the treatment of anorexia nervosa. The study is supported by a philanthropic gift from Baszucki Group.
May 23, 2023 — Jan Ellison Baszucki penned an op-ed in the San Francisco Chronicle to share her family’s journey of using a ketogenic diet to treat her son’s bipolar disorder.
May 11, 2023 — Baszucki Group awarded a grant to a Stony Brook University research team to study brain circuits with the creation of a ground-breaking neuroscience software, Neuroblox.
May 8, 2023 — Baszucki Group announced a philanthropic gift to Stony Brook University to develop Neuroblox, a software platform that will model brain circuits to treat brain disorders. The cutting-edge platform will open up a world of modeling possibilities for neuroscientists without training in computational sciences.